Cargando…
Characteristics and long‐term outcomes of advanced pleural mesothelioma in Latin America (MeSO‐CLICaP)
BACKGROUND: Malignant pleural mesothelioma (MPM) is an aggressive tumor, associated with poor prognosis. There is a lack of information about the clinical and pathological features related with survival in the Latin American population. METHODS: The MeSO‐CLICaP registry identified 302 patients with...
Autores principales: | Rojas, Leonardo, Cardona, Andrés F., Trejo‐Rosales, Rogelio, Zatarain‐Barrón, Zyanya Lucia, Ramírez‐Tirado, Laura‐Alejandra, Ruiz‐Patiño, Alejandro, Campos Gómez, Saúl, Corrales, Luis, Oblitas, George, Bacon, Ludwing, Martín, Claudio, de Lima, Vladmir C. Cordeiro, Freitas, Helano C., Mas, Luis, Vargas, Carlos, Carranza, Hernán, Otero, Jorge, Pérez, María Angelina, González, Lisde, Chirinos, Luis, Granados, Sara T., Rodriguez, July, Báez, Renata, Remolina Bonilla, Yuly‐Andrea, Núñez Cerrillo, Gustavo, Archila, Pilar, Cuello, Mauricio, Karachaliou, Niki, Rosell, Rafael, Arrieta, Oscar |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley & Sons Australia, Ltd
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6397921/ https://www.ncbi.nlm.nih.gov/pubmed/30706690 http://dx.doi.org/10.1111/1759-7714.12967 |
Ejemplares similares
-
Multigene Mutation Profiling and Clinical Characteristics of Small-Cell Lung Cancer in Never-Smokers vs. Heavy Smokers (Geno1.3-CLICaP)
por: Cardona, Andrés F., et al.
Publicado: (2019) -
Characteristics and outcomes of thymomas in Latin America: Results from over 10 years of experience (CLICaP‐LATimus)
por: Martín, Claudio, et al.
Publicado: (2021) -
Genotyping Squamous Cell Lung Carcinoma in Colombia (Geno1.1-CLICaP)
por: Cardona, Andrés F., et al.
Publicado: (2020) -
Antibiotics impair immune checkpoint inhibitor effectiveness in Hispanic patients with non‐small cell lung cancer (AB‐CLICaP)
por: Ruiz‐Patiño, Alejandro, et al.
Publicado: (2020) -
Immunotherapy at any line of treatment improves survival in patients with advanced metastatic non‐small cell lung cancer (NSCLC) compared with chemotherapy (Quijote‐CLICaP)
por: Ruiz‐Patiño, Alejandro, et al.
Publicado: (2019)